Comments
FDA grants orphan status to Lexicon tumor drug, shares rise
21.03.2012. | (Reuters) - The U.S. Food and Drug Administration granted orphan drug status to Lexicon Pharmaceuticals Inc's experimental tumor drug, sending the biopharmaceutical company's shares up 11 percent in extended trade....
